Last reviewed · How we verify

NCT05005962: PRAAN

Prospective Registry for Assessment of Acute Ischemic Stroke Patients Treated With Neurothrombectomy Devices in India

Completed Last updated 30 May 2024
What this trial tests

trial testing Neurothrombectomy in Acute Ischemic Stroke in 200 participants. Completed in 21 May 2024.

Timeline
30 August 2021
Primary endpoint
31 January 2024
21 May 2024

Quick facts

Lead sponsorMedtronic Neurovascular Clinical Affairs
StatusCompleted
Study typeOBSERVATIONAL
Enrollment200
Start date30 August 2021
Primary completion31 January 2024
Estimated completion21 May 2024
Sites14 locations across India

Drugs / interventions tested

Conditions studied

Sponsor

Medtronic Neurovascular Clinical Affairs — full company profile →

Who can join

18 and older, any sex, with Acute Ischemic Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

PRAAN is a post-market registry designed to collect real-world data associated with the use of Medtronic market release neurothrombectomy devices in acute ischemic stroke (AIS) patients from India.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Neurothrombectomy

Trials testing the same drug.

Other recruiting trials for Acute Ischemic Stroke

Currently open trials in the same condition.

Other Medtronic Neurovascular Clinical Affairs trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05005962.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing